Shares of Vitamin Shoppe Inc. (NYSE:VSI) shot up 1.9% on Monday . The company traded as high as $31.94 and last traded at $31.67, with a volume of 318,727 shares traded. The stock had previously closed at $31.08.

A number of research firms have recently weighed in on VSI. Zacks Investment Research raised shares of Vitamin Shoppe from a “hold” rating to a “buy” rating and set a $32.00 target price on the stock in a research report on Tuesday, May 24th. Robert W. Baird reissued a “hold” rating on shares of Vitamin Shoppe in a research report on Monday, May 16th. Sterne Agee CRT reissued a “neutral” rating on shares of Vitamin Shoppe in a research report on Monday, May 16th. Jefferies Group reissued a “hold” rating and set a $32.00 price objective (up from $30.00) on shares of Vitamin Shoppe in a research report on Friday, May 6th. Finally, Macquarie reissued a “neutral” rating and set a $40.00 price objective on shares of Vitamin Shoppe in a research report on Thursday, May 5th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. Vitamin Shoppe presently has an average rating of “Hold” and an average price target of $32.82.

The firm has a market cap of $742.34 million and a PE ratio of 17.76. The firm has a 50-day moving average of $30.77 and a 200 day moving average of $29.94.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, May 4th. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.65 by $0.02. The firm earned $336.80 million during the quarter, compared to the consensus estimate of $339.76 million. During the same quarter in the previous year, the firm earned $0.63 earnings per share. The business’s revenue was up .0% compared to the same quarter last year. On average, equities analysts expect that Vitamin Shoppe Inc. will post $2.32 earnings per share for the current fiscal year.

In other news, Director Guillermo Marmol acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 31st. The stock was purchased at an average cost of $30.23 per share, for a total transaction of $30,230.00. Following the completion of the acquisition, the director now directly owns 1,470 shares of the company’s stock, valued at approximately $44,438.10. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Several hedge funds have recently added to or reduced their stakes in VSI. Employees Retirement System of Texas purchased a new stake in Vitamin Shoppe during the fourth quarter valued at $1,275,000. Rhumbline Advisers raised its position in Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock valued at $1,475,000 after buying an additional 1,855 shares during the period. Gabelli Funds LLC raised its position in Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock valued at $1,734,000 after buying an additional 7,000 shares during the period. California State Teachers Retirement System raised its position in Vitamin Shoppe by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 55,107 shares of the company’s stock valued at $1,802,000 after buying an additional 885 shares during the period. Finally, State of Wisconsin Investment Board raised its position in Vitamin Shoppe by 0.8% in the fourth quarter. State of Wisconsin Investment Board now owns 159,102 shares of the company’s stock valued at $5,203,000 after buying an additional 1,229 shares during the period.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.